S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS

• Fabian Lang,
• Heike Pfeifer,
• Simon Raffel,
• Walter Fiedler,
• Maher Hanoun,
• Mathias Hänel,
• Bernd Spriewald,
• Andreas Viardot,
• Vladan Vucinic,
• Hubert Serve,
• Dieter Hoelzer,
• Nicola Gökbuget

Affiliations

Fabian Lang

1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany

Heike Pfeifer

1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany

Simon Raffel

2 University of Heidelberg, Department of Hematology, Oncology and Rheumatology, Heidelberg, Germany

Walter Fiedler

3 Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Maher Hanoun

4 Universitätsklinikum Essen, Department of Bone Marrow Transplantation, Essen, Germany

Mathias Hänel

5 Küchwald Hospital Chemnitz, Department of Internal Medicine III, Chemnitz, Germany

Bernd Spriewald

6 University Hospital Erlangen, Department of Internal Medicine 5, Erlangen, Germany

Andreas Viardot

7 University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany

Vladan Vucinic

8 University Leipzig Medical Center, Clinic and Policlinic for Hematology, Celltherapy and Hemostaseology, Leipzig, Germany

Hubert Serve

1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany

Dieter Hoelzer

9 Onkologikum, Goethe University, Frankfurt am Main, Germany

Nicola Gökbuget

1 Goethe University Hospital, Department of Medicine, Hematology and Oncology, Frankfurt am Main, Germany